Cargando…
Dupilumab‐associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting
BACKGROUND/OBJECTIVES: Dupilumab‐associated ocular surface disease (DAOSD) is of particular relevance in patients with atopic dermatitis (AD). Guidance on DAOSD assessment and management in the Australian setting is needed to reduce its impact and minimise disruption to treatment. METHODS: A systema...
Autores principales: | Foley, Peter, Kerdraon, Yves A., Hogden, John P., Shumack, Stephen, Spelman, Lynda, Sebaratnam, Deshan F., Su, Charles S., Katelaris, Constance H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826507/ https://www.ncbi.nlm.nih.gov/pubmed/36125089 http://dx.doi.org/10.1111/ajd.13924 |
Ejemplares similares
-
Ocular allergy in the Asia Pacific region
por: Katelaris, Constance H.
Publicado: (2011) -
Biologics for severe, chronic plaque psoriasis: An Australian cost-utility analysis
por: Sun, Helen Y., et al.
Publicado: (2021) -
Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature
por: Lobo, Yolanka, et al.
Publicado: (2021) -
Dupilumab-associated cicatrizing ocular disease
por: Reddy, Amit K., et al.
Publicado: (2022) -
Method of Assessing Skin Cancerization and Keratoses(TM) (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerization
por: Baker, Christopher, et al.
Publicado: (2022)